您的位置: 首页 > 农业专利 > 详情页

DOSING SCHEDULE OF A WNT INHIBITOR AND AN ANTI-PD-1 ANTIBODY MOLECULE IN COMBINATION
专利权人:
Novartis AG
发明人:
Jason Russell DOBSON,Susan MOODY,Margaret Elise McLAUGHLIN
申请号:
US16482836
公开号:
US20190365746A1
申请日:
2018.02.12
申请国别(地区):
US
年份:
2019
代理人:
摘要:
The present disclosure relates to the field of pharmacy, particularly to a Wt inhibitor and a PD-1 inhibitor for use in the treatment of cancer. Specifically, the disclosure relates to a pharmaceutical combination comprising a Wnt inhibitor, or a pharmaceutically acceptable salt thereof, and a PD-1 inhibitor, or a pharmaceutically acceptable salt thereof, for use in the treatment of cancer, to a method for the treatment of cancer that involves administering the combination and to the use of the combination for the manufacture of a medicament for the treatment of cancer.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充